["We have a high research potential." Prof. Dr. med. H. D. Schlumberger, Bayer, and Dr. E. Schrinner, Hoechst, interpret the cooperation of both companies in AIDS research. Interview by T. U. Keil].
Schlumberger
H D
HD
Schrinner
E
E
D000163:Acquired Immunodeficiency Syndrome / Q000188:drug therapy*; D000998:Antiviral Agents / Q000627:therapeutic use*; D004345:Drug Industry; D005860:Germany, West; D006801:Humans; D012106:Research
D000998:Antiviral Agents
"Wir haben ein hohes Forschungspotential." Prof. Dr. med. H. D. Schlumberger, Bayer, und Dr. E. Schrinner, Hoechst, interpretieren die Kooperation beider Firmen in Sachen AIDS.